Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$498.29 - $574.41 $45,842 - $52,845
-92 Reduced 13.92%
569 $288,000
Q2 2023

Aug 09, 2023

SELL
$508.46 - $591.13 $29,999 - $34,876
-59 Reduced 8.19%
661 $344,000
Q1 2023

May 10, 2023

BUY
$535.0 - $604.82 $385,200 - $435,470
720 New
720 $414,000
Q1 2022

May 11, 2022

SELL
$524.0 - $644.92 $275,624 - $339,227
-526 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$569.0 - $667.24 $23,329 - $27,356
-41 Reduced 7.23%
526 $351,000
Q3 2021

Nov 12, 2021

SELL
$509.53 - $609.78 $146,744 - $175,616
-288 Reduced 33.68%
567 $324,000
Q2 2021

Aug 10, 2021

BUY
$441.0 - $508.24 $44,541 - $51,332
101 Added 13.4%
855 $431,000
Q1 2021

May 14, 2021

SELL
$439.85 - $518.83 $481,635 - $568,118
-1,095 Reduced 59.22%
754 $344,000
Q4 2020

Feb 12, 2021

BUY
$435.06 - $527.66 $147,485 - $178,876
339 Added 22.45%
1,849 $861,000
Q3 2020

Oct 30, 2020

SELL
$359.77 - $441.52 $68,356 - $83,888
-190 Reduced 11.18%
1,510 $667,000
Q2 2020

Aug 13, 2020

SELL
$275.2 - $362.34 $762,579 - $1 Million
-2,771 Reduced 61.98%
1,700 $616,000
Q1 2020

May 15, 2020

BUY
$255.3 - $340.05 $335,208 - $446,485
1,313 Added 41.58%
4,471 $1.27 Million
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $263,500 - $317,870
-969 Reduced 23.48%
3,158 $1.03 Million
Q3 2019

Nov 13, 2019

SELL
$268.46 - $305.43 $105,504 - $120,033
-393 Reduced 8.69%
4,127 $1.2 Million
Q2 2019

Aug 14, 2019

BUY
$257.51 - $295.55 $133,905 - $153,686
520 Added 13.0%
4,520 $1.33 Million
Q1 2019

May 10, 2019

SELL
$212.17 - $273.72 $177,374 - $228,829
-836 Reduced 17.29%
4,000 $1.1 Million
Q4 2018

Feb 14, 2019

BUY
$208.47 - $251.98 $1.01 Million - $1.22 Million
4,836 New
4,836 $1.08 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Rock Creek Group, LP Portfolio

Follow Rock Creek Group, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Creek Group, LP with notifications on news.